MAP2 Antikörper
-
- Target Alle MAP2 Antikörper anzeigen
- MAP2 (Microtubule-Associated Protein 2 (MAP2))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser MAP2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- Cytoplasm
- Aufreinigung
- Protein G-Sepharose affinity purified.
- Immunogen
- Recombinant fragment of Human MAP2 (C-terminus).
- Isotyp
- IgG
- Top Product
- Discover our top product MAP2 Primärantikörper
-
anti-Microtubule-Associated Protein 2 (MAP2) antibody
MAP2 Reaktivität: Human, Maus, Schwein WB, ELISA, ICC, IHC (p), IP, IHC (fro) Wirt: Maus Monoclonal MT-08 unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) (AA 260-559) antibodyMAP2 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) (AA 350-400) antibodyMAP2 Reaktivität: Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) antibodyMAP2 Reaktivität: Rind (Kuh) WB, IF, ICC Wirt: Huhn Polyclonal unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) antibodyMAP2 Reaktivität: Human, Maus, Ratte IF, IHC (p) Wirt: Maus Monoclonal unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) antibodyMAP2 Reaktivität: Human WB, IF, IHC (p) Wirt: Maus Monoclonal 159CT34-12-3-4 unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) antibodyMicroarray verified MAP2 Reaktivität: Human, Maus IHC Wirt: Maus Monoclonal MAB573626 unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) (N-Term) antibodyMAP2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) (AA 727-985) antibodyMAP2 Reaktivität: Human WB, ELISA, ICC, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein 2 (MAP2) (AA 1459-1718) antibodyMAP2 Reaktivität: Ratte WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilutions. ELISA: 1/5000 - 1/20000. WB: 1/100-1/2000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 50µg/50µl
- Buffer
- 0.02% Sodium Azide and 50% glycerol, 1% BSA, PBS, pH7.4.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- MAP2 (Microtubule-Associated Protein 2 (MAP2))
- Andere Bezeichnung
- MAP2 (MAP2 Produkte)
- Synonyme
- MAP2A antikoerper, MAP2B antikoerper, MAP2C antikoerper, MAP2R antikoerper, Mtap2 antikoerper, MAP-2 antikoerper, Mtap-2 antikoerper, xmap2 antikoerper, MGC53131 antikoerper, a730034c02 antikoerper, zgc:103474 antikoerper, zgc:113974 antikoerper, microtubule associated protein 2 antikoerper, microtubule-associated protein 2 antikoerper, microtubule associated protein 2 S homeolog antikoerper, MAP2 antikoerper, Map2 antikoerper, map2.S antikoerper, map2 antikoerper
- Hintergrund
- Microtubule-associated protein 2 (MAP2) is a neuronal phosphoprotein that regulates the structure and stability of microtubules, neuronal morphogenesis, cytoskeleton dynamics and organelle trafficking in axons and dendrites. Phosphorylation of MAP2 modulates its association with the cytoskeleton and is developmentally regulated. Serine 136, threonine 1620 and threonine 1623 of MAP2 are phosphorylated by GSK3 and p44/42 MAP kinases. Phosphorylation at threonine 1620/1623 by GSK3 inhibits MAP2 association with microtubules and microtubule stability.
- Molekulargewicht
- 50kDa
- NCBI Accession
- NM_031846
-
